Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cigna Corp (NY:CI)

247.10 -52.02 (-17.39%)
Official Closing Price Updated: 7:00 PM EDT, Oct 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cigna Corp

< Previous 1 2
...
20 21 22 23 24 25 26 27 28
...
35 36 Next >
What Older Adults Should Know After a Doctor’s Visit
Via StatePoint Media
11 Stocks: 9 Dividend Payers 2 For Growth
Not all stocks are the same, and not all stocks serve the investor’s needs. 
Via Talk Markets
Does Big Pharmacy Managers Fix Prices? Ohio Attorney General Lawsuit Alleges Cigna, Humana Engaged In Price Fixing For Medicines
A lawsuit filed by the Ohio attorney general alleges that Cigna Corp (NYSE: CI), Humana Inc (NYSE: HUM), and Prime Therapeutics LLC shared pricing and other information to gain le 
Via Benzinga
Small Medium Enterprise Insurance Market to Eyewitness Massive Growth by 2027 : Cigna, Frankenmuth Insurance, Liberty Mutual
Advance Market Analytics published a new research publication on "Small Medium Enterprise Insurance Market Insights, to 2027" with 232 pages and enriched with self-explained Tables and charts in... 
Via SBWire
This Is What Whales Are Betting On Cigna Group
 
Via Benzinga
Individual Insurance Market Seeking Excellent Growth : Allianz, Allstate, Oscar, Daman
Stay up-to-date with Individual Insurance Market research offered by AMA Research. Check how key trends and emerging drivers are shaping this industry growth. 
Via SBWire
A Bearish Sign Appears On Cigna Group's Chart
 
Via Benzinga
Analyst Expectations for Cigna Group's Future
 
Via Benzinga
Kobie Voted a Top Workplace USA
Kobie, a globally recognized industry leader in loyalty technology and services, has been named one of the Top Workplaces USA.ST. PETERSBURG, Fla. - March 24, 2023 - PRLog -- Kobie, a globally... 
Via PRLog
Topics Bonds
Veterans' Access to SUD Treatment Aided with CRC and TriWest Partnership
Veterans’ Access to SUD Treatment Aided with CRC and TriWest Partnership - IssueWire 
Via IssueWire
Peering Into Cigna Group's Recent Short Interest
 
Via Benzinga
Small Medium Enterprise Insurance Market Is Booming Worldwide : Munich Re, Liberty Mutual, Aviva, Cigna
Small Medium Enterprise Insurance Comprehensive Study by Type (Property Insurance, Liability Insurance, Business Auto Insurance, Workers Compensation Insurance), Application (Retail, Telecom Industry,... 
Via SBWire
Medicare Advisors’ licensed agents offer personalized support for finding the best Medicare Advantage plans
Via Get News
What 7 Analyst Ratings Have To Say About Cigna
 
Via Benzinga
Cigna (CI) Q4 2022 Earnings Call Transcript
CI earnings call for the period ending December 31, 2022. 
Via The Motley Fool
Cigna Q4 Results Beat Street View, Forecasts Higher FY23 Earnings, But Below Wall Street
  
Via Benzinga
Earnings Outlook For Cigna
 
Via Benzinga
Lemonade Earnings Gap and Crap. Here’s Why.
Online Insurance platform Lemonade Inc. (NYSE: LMND) stock surged to $18.88 from $16.44 after releasing its Q4 2022 earnings. However, shares cratered back 
Via MarketBeat
Topics Artificial Intelligence Economy
AM Best Assigns Issue Credit Ratings to The Cigna Group’s New Senior Unsecured Notes
From AM Best
Via Business Wire
What is a Blue Chip Company? Examples of Blue Chips
A blue chip is a publicly traded, well-established, financially sound company. Learn more about blue chips with MarketBeat. 
Via MarketBeat
Topics Stocks
How To Attend Cigna Q4 2022 Earnings Conference Call
 
Via Benzinga
Want to Get Richer? Buy This Blue Chip Dividend Stock and Don't Let Go
This managed care company serves hundreds of millions of customers. 
Via The Motley Fool
NVIDIA To Rally Over 20%? Here Are 10 Other Analyst Forecasts For Thursday
Goldman Sachs boosted the price target for Vir Biotechnology, Inc. (NASDAQ: VIR) from $41 to $53. Goldman Sachs analyst Paul Choi maintained a Buy rating on the stock. Vir Biotechnology shares rose... 
Via Benzinga
Got $300? 3 Growth Stocks to Buy That Could Double Your Money
All three companies have shown consistent revenue and EPS growth. 
Via The Motley Fool
Child Health Insurance Market to See Huge Growth : Cigna, GeoBlue, William Russell, Axa
Stay up-to-date with Child Health Insurance Market research offered by AMA Research. Check how key trends and emerging drivers are shaping this industry growth. 
Via SBWire
Market Rally Powers Higher On Tame Fed, Meta Earnings; Apple, Google, Amazon In Focus: Weekly Review
The major indexes continued to run despite mixed-to-weak earnings. 
Via Investor's Business Daily
Nasdaq Futures Deflate As Apple Leads Tech Disappointments: Traders Look To Jobs Data For Mitigating Impact
Trading in the U.S. index futures suggests stocks may end a solidly positive week on a negative note. That said, the data-dependency of the Fed places the onus of providing trading cues to each... 
Via Benzinga
Alphabet, Apple And 3 Stocks To Watch Heading Into Friday
With Nasdaq stock futures trading lower this morning on Friday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
Fear & Greed Index Remains In 'Greed' Zone As Nasdaq Record Sharp Gains For Fourth Straight Week
The CNN Money Fear and Greed index showed some decline in overall sentiment among US investors. US stocks closed mostly higher on Thursday, with the tech-laden Nasdaq index leading the rally. Investors... 
Via Benzinga
How Medicare Advantage Insurers Will Be Affected By Proposed 2024 Payment Cut
Medicare Advantage insurers might see an average 2.27% reduction in baseline payments in 2024, the Centers for Medicare and Medicaid Services said Wednesday. 
Via Benzinga
< Previous 1 2
...
20 21 22 23 24 25 26 27 28
...
35 36 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.